Volume 22 - Issue 7 - July 2014
Column
Chief Medical Editor Message
04/07/2016
Over the past 20 years, we have witnessed extraordinary changes in how psoriasis is managed. Biologic treatments have revolutionized the outcomes we can help patients with moderate-to-severe psoriasis achieve. Long gone are the days where the...
Over the past 20 years, we have witnessed extraordinary changes in how psoriasis is managed. Biologic treatments have revolutionized the outcomes we can help patients with moderate-to-severe psoriasis achieve. Long gone are the days where the...
Over the past 20 years, we have...
04/07/2016
The Dermatologist
04/06/2016
Significant differences in quality of life (QOL) and use of prescription topical medication exist between patients with clear skin compared to patients with almost clear skin, ultimately suggesting that clear skin is the indicator of the...
Significant differences in quality of life (QOL) and use of prescription topical medication exist between patients with clear skin compared to patients with almost clear skin, ultimately suggesting that clear skin is the indicator of the...
Significant differences in...
04/06/2016
The Dermatologist
04/06/2016
A recent study found that psoriasis patients who have previously undergone multiple phototherapy treatments experience shorter remission periods when being treated with narrowband ultraviolet B (NB-UVB) phototherapy. Ryu et al conducted a...
A recent study found that psoriasis patients who have previously undergone multiple phototherapy treatments experience shorter remission periods when being treated with narrowband ultraviolet B (NB-UVB) phototherapy. Ryu et al conducted a...
A recent study found that...
04/06/2016
The Dermatologist
04/06/2016
A recent study examined the clinical evidence related to photodynamic therapy for psoriasis, which showed promise in the early 1990s as a treatment of plaque clearance following topical aminolevulinic acid-photodynamic therapy (ALA-PDT). In...
A recent study examined the clinical evidence related to photodynamic therapy for psoriasis, which showed promise in the early 1990s as a treatment of plaque clearance following topical aminolevulinic acid-photodynamic therapy (ALA-PDT). In...
A recent study examined the...
04/06/2016
The Dermatologist
04/06/2016
Narrowband UVB (NB-UVB) phototherapy is used for treatment of psoriasis, though the mechanisms underlying its efficacy are unclear. In a recent study, researchers used gene expression profiling to characterize gene expression in lesional...
Narrowband UVB (NB-UVB) phototherapy is used for treatment of psoriasis, though the mechanisms underlying its efficacy are unclear. In a recent study, researchers used gene expression profiling to characterize gene expression in lesional...
Narrowband UVB (NB-UVB)...
04/06/2016
The Dermatologist
04/06/2016
During 2014 The Dermatologist’s sister publication, First Report Managed Care, conducted a survey of professionals in the managed care specialty pharmacy field to determine trends in managed care with a focus on specialty pharmacy. The survey...
During 2014 The Dermatologist’s sister publication, First Report Managed Care, conducted a survey of professionals in the managed care specialty pharmacy field to determine trends in managed care with a focus on specialty pharmacy. The survey...
During 2014 The Dermatologist’s...
04/06/2016
The Dermatologist
04/06/2016
National Psoriasis Foundation (NPF) has announced plans to launch the largest realignment and expansion of its psoriatic arthritis (PsA) program since the organization began serving this community nearly 20 years ago. The NPF has provided...
National Psoriasis Foundation (NPF) has announced plans to launch the largest realignment and expansion of its psoriatic arthritis (PsA) program since the organization began serving this community nearly 20 years ago. The NPF has provided...
National Psoriasis Foundation...
04/06/2016
The Dermatologist
08/18/2014
Cynosure, Inc. received FDA 510(k) clearance to market the PicoSure Picosecond Laser Workstation for the treatment of acne scars with the FOCUS lens array
Cynosure, Inc. received FDA 510(k) clearance to market the PicoSure Picosecond Laser Workstation for the treatment of acne scars with the FOCUS lens array
Cynosure, Inc. received FDA...
08/18/2014
The Dermatologist
News
News
08/19/2014
To help physicians who would like to better be able to follow a patient’s progress while taking Promius Pharma’s generic isotretinoin capsules USP (Zenatane), the company has created a web-based provider portal, which is designed to allow any...
To help physicians who would like to better be able to follow a patient’s progress while taking Promius Pharma’s generic isotretinoin capsules USP (Zenatane), the company has created a web-based provider portal, which is designed to allow any...
To help physicians who would...
08/19/2014
The Dermatologist
News
07/23/2014
Data from PALACE 4 demonstrated clinically meaningful improvements in enthesitis, dactylitis and physical function with apremilast (Otezla, Celgene Corp) that were sustained up to 52 weeks of treatment. Apremilast, approved by the FDA in...
Data from PALACE 4 demonstrated clinically meaningful improvements in enthesitis, dactylitis and physical function with apremilast (Otezla, Celgene Corp) that were sustained up to 52 weeks of treatment. Apremilast, approved by the FDA in...
Data from PALACE 4 demonstrated...
07/23/2014
The Dermatologist
